Key facts
- BabyOrgano’s last known valuation is $4.8M (Aug 2024).
- It has raised $3.2M; the latest was Early Stage VC ($2.3M) in Nov 2025.
- Notable investors include Sauce.vc, AIC ISB, CII Centre of Excellence for Innovation, DevX (Consulting Services (B2B)), Entrepreneurship and Startups — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for BabyOrgano
- ·The full record, as it builds
Funding rounds
No funding rounds for BabyOrgano are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About BabyOrgano
Operator of a baby health care and wellness brand intended to offer natural and eco-friendly body care alternatives. The company provides a range of organic products, including body lotions, rash creams, hair shampoo, body wash, massage oil, and various wellness goods for kids, enabling customers to get toxin-free substitutes and maintain the well-being of babies.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Ahmedabad, India
- Founded
- 2022
- Employees
- 58
- Website
- babyorgano.com/
- Ownership
- Privately Held (backing)
BabyOrgano doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in BabyOrgano shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on BabyOrgano in its N-PORT filings yet. We sweep new filings monthly.